AVAdeno Study: An Observational Study of First-Line Avastin (Bevacizumab) in Patients With Adenocarcinoma of the Lung

NCT01827852 · clinicaltrials.gov ↗

COMPLETED

Status

1107

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Squamous Non-Small Cell Lung Cancer

Sponsor

Hoffmann-La Roche